---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-028800"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:29:19.853088+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics shareholders elect three Class II directors and ratify auditor at 2024 annual meeting

## Summary
- Steven A. Elms, Adam S. Grossman, Young T. Kwon elected as Class II directors with 71%, 97%, 98% of votes cast excluding broker non-votes.
- Ratification of CohnReznick LLP as independent auditor for FY2024 approved with 184.5M for, 2.0M against, 0.2M abstain.
- Annual meeting quorum achieved with 186.7M shares represented out of 231.8M outstanding (80.5% of shares).

## SEC filing metadata
- accession: 0001140361-24-028800
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/0001140361-24-028800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/ef20030555_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-028800
- JSON: https://secwatch.observer/filing/0001140361-24-028800.json
- Plain text: https://secwatch.observer/filing/0001140361-24-028800.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.